The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone

DeFronzo, Ralph A., Hissa, Miguel N., Garber, Alan J., Luiz Gross, Jorge, Yuyan Duan, Raina, Ravichandran, Shoba, Chen, Roland S., for the Saxagliptin 014 Study Group·2009·Diabetes Care
DOI 10.2337/dc08-1984

Cited by (415)

Items 401–415 of 415

  1. Current awareness: Pharmacoepidemiology and drug safety
    2010 · Pharmacoepidemiology and Drug Safety
  2. The Role of Incretins in Insulin Secretion
    Marzieh Salehi · 2017 · Springer eBooks
  3. Current literature in diabetes
    2010 · Diabetes/Metabolism Research and Reviews
  4. Thérapeutique des désordres glycémiques
    2019 · Elsevier eBooks
  5. The authors respond:
    Vincent C. Woo, ALICE Y.Y. CHENG, Amir Hanna, Lori Berard · 2010 · Canadian Journal of Diabetes
  6. References, Bibliography & Further Reading
    2012 · Elsevier eBooks
  7. Saxagliptin: a guide to its use in type 2 diabetes mellitus
    &NA; · 2010 · Drugs & Therapy Perspectives
  8. A dipeptidyl peptidase-4 inhibitor for adults with type 2 diabetes.
    2010 · PubMed Central
  9. Gut Hormones and Metabolic Syndrome
    Salman Zahoor Bhat, Hyeong Kyu Park, Rexford S. Ahima · 2023 · Springer eBooks
  10. Expert perspectives on the use of combination therapies for glycemic control in newly diagnosed type 2 diabetes mellitus in Indian settings
    S.N. Manjula, Krishna Kumar M · 2025 · International Journal of Endocrinology Sciences
  11. A multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice ( PIONEER REAL Japan): Subgroup analyses
    Daisuke Yabe, Yoshiyuki Hamamoto, Daiji Kawanami, Rimei Nishimura, Yasuo Terauchi, Hanan Amadid, Uffe Christian Braae, Atheline Major‐Pedersen, Ryo Suzuki · 2025 · Journal of Diabetes Investigation
  12. Dipeptidyl peptidase 4 (DPP-4) inhibitors for people with chronic kidney disease and diabetes
    Patrizia Natale, Suetonia C. Green, David J. Tunnicliffe, Giovanni Pellegrino, Tadashi Toyama, Giovanni FM Strippoli, supported by Cochrane Kidney and Transplant · 2025 · Cochrane Database of Systematic Reviews
  13. Gastric Neoplasm Risk with DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: Network Meta-Analysis of Randomized Trials
    Chao-Ming Hung, Chih‐Wei Hsu, Bing-Syuan Zeng, Mein‐Woei Suen, Jiann-Jy Chen, Bing‐Yan Zeng, Andre F. Carvalho, Brendon Stubbs, Yen-Wen Chen, Tien-Yu Chen et al. · 2026 · International Journal of Molecular Sciences
  14. Reassessing the risk-modifying effects of novel antidiabetic agents on asthma–COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults from 128 randomised trials
    Bing‐Yan Zeng, Chih-Wei Hsu, Chao‐Ming Hung, Wei-Chieh Yang, Brendon Stubbs, Yen-Wen Chen, Wei-Te Lei, Jiann-Jy Chen, Tien‐Yu Chen, Shih‐Pin Hsu et al. · 2026 · EClinicalMedicine
  15. Comparative cardiovascular efficacy of antidiabetic therapies in type 2 diabetes: a systematic review and network meta-analysis of randomized trials
    Donya Mohammadi, Behnam Sadeghirad, Mohammad Aziz Rasouli, Lotfollah Saed, Hamid Reza Baradaran, Yousef Moradi · 2026 · Diabetology & Metabolic Syndrome